Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia (Q39224200)

10 September 2017

Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia (English)

1 reference

10 September 2017

1 reference

1 reference

Hiroyuki Yamada

1

1 reference

10 September 2017

Kazutoshi Iijima

2

1 reference

10 September 2017

Osamu Tomita

3

1 reference

10 September 2017

Tomoko Taguchi

4

1 reference

10 September 2017

Masashi Miharu

5

1 reference

10 September 2017

Kenichiro Kobayashi

6

1 reference

10 September 2017

Hajime Okita

7

1 reference

10 September 2017

Masahiro Saito

8

1 reference

10 September 2017

Toshiaki Shimizu

9

1 reference

10 September 2017

Nobutaka Kiyokawa

10

1 reference

10 September 2017

19 December 2012

1 reference

International Journal of Hematology

10 September 2017

1 reference

10 September 2017

97

1 reference

10 September 2017

73-82

1 reference

10 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-012-1234-3

10 September 2017

0 references

cites work

Structural origins of the functional divergence of human insulin-like growth factor-I and insulin

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Structural biology of insulin and IGF1 receptors: implications for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

The insulin-like growth factor-binding protein (IGFBP) superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1234-3

Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

12 December 2020

Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation.

1 reference

12 December 2020

Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins

1 reference

12 December 2020

Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells

1 reference

12 December 2020

Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk

1 reference

12 December 2020

10.1007/S12185-012-1234-3

Identifiers

DOI

1 reference

10 September 2017

1 reference